Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016719 (
Friedreich's ataxia
)
2,098
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The severe reduction in mRNA and protein levels of the mitochondrial protein frataxin, encoded by the X25 gene, causes
Friedreich ataxia
(
FRDA
), the most common form of recessive hereditary ataxia. Increasing evidence underlines the pathogenetic role of oxidative stress in this disease. We generated an in vitro cellular model of regulated human frataxin overexpression. We identified, by differential display technique, the mitogen activated protein kinase kinase 4 mRNA down regulation in frataxin overexpressing cells. We studied the stress kinases pathway in this cellular model and in fibroblasts from
FRDA
patients. Frataxin overexpression reduced c-Jun N-terminal kinase phosphorylation. Furthermore, exposure of
FRDA
fibroblasts to several forms of environmental stress caused an up regulation of phospho-
JNK
and phospho-c-Jun. To understand if this susceptibility results in cell death, we have investigated the involvement of caspases. A significantly higher activation of caspase-9 was observed in
FRDA
versus control fibroblasts after serum-withdrawal. Our findings suggest the presence, in
FRDA
patient cells, of a 'hyperactive' stress signaling pathway. The role of frataxin in
FRDA
pathogenesis could be explained, at least in part, by this hyperactivity.
...
PMID:Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. 1239 10